Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
Pathways Chemical Dependency Services located in Saginaw, MI, provides a wide range of addiction rehabilitation options, including inpatient detox and treatment programs. This center caters to adult men and women, along with young adults, particularly those facing both mental health issues and substance use disorders. By employing proven methods such as 12-step programs, cognitive behavioral therapy, and short intervention strategies, the facility creates customized treatment plans designed for each client. With a strong emphasis on delivering high-quality, gender-sensitive care, Pathways Chemical Dependency Services is committed to assisting individuals in their recovery journey.
Situated in Sandy Hook, KY, Pathways Inc delivers a wide range of outpatient rehabilitation options for both adults and children who are facing challenges related to substance abuse and concurrent mental health conditions. The center features tailored treatment programs designed for individuals impacted by intimate partner violence, including those with dual diagnoses. Pathways Inc employs research-backed methods, such as cognitive behavioral therapy and anger management techniques, to facilitate recovery and healing. Prioritizing care for adolescents, adults, and seniors across all genders, this facility provides essential services like outpatient methadone and buprenorphine therapy, establishing itself as a critical support system for those in need of compassionate and effective rehabilitation.
Situated in Greenville, GA, Pathways Center specializes in outpatient treatment for substance use disorders and provides targeted support for those facing both substance use issues and severe mental health challenges. The center offers various treatment options, including outpatient services with medications such as methadone, buprenorphine, or naltrexone. Emphasizing evidence-based methodologies, Pathways Center incorporates strategies like anger management, cognitive behavioral therapy, and contingency management to assist diverse populations including adolescents and adults of all genders. With programs tailored to both men and women, the center prioritizes high-quality, gender-sensitive care for clients of all ages.
Pathways Center, located in Griffin, GA, provides outpatient services for individuals dealing with substance use challenges, as well as tailored care for adults with co-occurring mental health disorders and children experiencing emotional issues. Their treatment options feature outpatient programs utilizing methadone, buprenorphine, and naltrexone, alongside standard outpatient services. The center employs proven techniques, including anger management programs, cognitive behavioral therapy, and community reinforcement approaches with vouchers. With dedicated programs for teenagers, and gender-specific care for adult men and women, Pathways Center serves a diverse clientele, ensuring personalized treatment plans aimed at fostering recovery and wellness.
Pathway to Recovery, located in Hazleton, PA, provides a wide array of rehabilitation services designed for those facing challenges with substance use disorders alongside mental health issues. The center encompasses various treatment options, including intensive outpatient therapy, standard outpatient services, and programs specifically for methadone, buprenorphine, or naltrexone. Emphasizing research-backed techniques such as cognitive behavioral therapy, anger management, and brief interventions, the facility customizes its offerings to address the individual needs of each client. It features specialized programs for adolescents, women, and those affected by domestic violence. Catering to adults and seniors of all genders, Pathway to Recovery is dedicated to offering exceptional, tailored care to assist individuals in their pursuit of sobriety and improved mental health.
Pathways, situated in Lynchburg, VA, delivers complete addiction recovery services for adults and younger individuals. They offer intensive outpatient programs, general outpatient services, and medication-assisted treatment options including methadone, buprenorphine, and naltrexone. Their approach emphasizes 12-step principles, emotional regulation techniques, and short-term counseling, all adapted to each person's unique situation. Pathways also features specialized support for active military members, men, and women. The center welcomes both male and female patients, fostering a nurturing atmosphere. Pathways is committed to providing excellent care and customized recovery plans to guide individuals toward lasting sobriety.
Pathway Society Inc in San Jose, CA, provides in-depth residential care for adult men grappling with addiction and co-occurring severe mental health challenges. Employing therapeutic modalities like anger control techniques, cognitive-behavioral strategies, and short-term counseling, this establishment delivers personalized support to individuals with histories of trauma, domestic abuse, or intimate partner violence. Prioritizing a complete recovery, the center serves adults, older adults, and younger adults, delivering custom treatment within a male-only setting. Pathway Society Inc is recognized for its all-encompassing services, empathetic professionals, and dedication to cultivating enduring sobriety.
Pathways Behavioral Services Inc, situated in Waterloo, IA, provides an extensive array of treatment alternatives for those pursuing recovery from addiction and concurrent mental health issues. The center offers a variety of programs, including intensive outpatient care, long-term residential treatment, and standard outpatient services, all grounded in research-supported methods like cognitive behavioral therapy and motivational interviewing. Tailored programs cater to specific groups such as teenagers, military families, pregnant or postpartum women, as well as adults and seniors of every gender. Emphasizing personalized care and effective treatment, this facility is dedicated to guiding clients toward sustainable recovery.
Pathways Behavioral Services Inc, located in Waverly, IA, provides outpatient care for adults facing substance use issues and co-occurring mental health disorders, as well as for children experiencing significant emotional challenges. The center's offerings encompass short intervention sessions, cognitive behavioral therapy, and motivational incentives alongside contingency management. Committed to delivering personalized care, Pathways serve a diverse clientele of adults and senior individuals, regardless of gender. By prioritizing high-quality, customized approaches, Pathways Behavioral Services Inc distinguishes itself through its dedication to developing tailored treatment plans that meet the specific needs of each person seeking assistance with addiction and mental well-being.
Pathways Center, situated in Lagrange, GA, delivers extensive outpatient treatment for adults facing substance use issues alongside mental health challenges, as well as for children dealing with severe emotional disturbances. The center employs a variety of proven methods, such as anger management, cognitive behavioral therapy, and motivational incentives. Customized programs for teenagers, men, and women are designed to provide personalized support. Pathways Center focuses on high-quality care tailored to different genders and age demographics, facilitating effective recovery paths. Whether pursuing standard outpatient care or medication-assisted treatment, this center fosters a nurturing atmosphere conducive to healing and development.
Situated in Carrollton, GA, Pathways Center delivers extensive outpatient recovery support for individuals of all ages facing addiction and overlapping mental health challenges. The facility features distinct treatment plans designed for the specific requirements of teenagers, adult men, and adult women. Employing proven therapeutic methods like cognitive behavioral therapy, anger management, and brief intervention, Pathways Center guarantees excellent support for those on their path to wellness. The center provides outpatient care using methadone, buprenorphine, or naltrexone, serving both male and female clients and fostering a nurturing space for recovery and personal development.
Situated in Newnan, GA, the Pathways Center Care Campus provides an extensive array of outpatient services designed for individuals aiming to recover from substance use issues and concurrent mental health disorders. The facility features dedicated programs catering to adults as well as children and teenagers, offering a variety of treatment approaches including detoxification, cognitive behavioral therapy, anger management, and brief interventions. What distinguishes this center is its commitment to assisting clients with co-occurring disorders, delivering personalized care to individuals facing multifaceted challenges. Pathways Center Care Campus accepts clients of all genders, ensuring they receive high-quality, evidence-based treatment to aid each person on their journey to wellness and recovery.
Pathways Center Care Campus, situated in Newnan, GA, provides extensive outpatient programs for drug and alcohol addiction. Their specialized services include outpatient detox and medication-assisted treatment options like methadone, buprenorphine, and naltrexone. The center employs evidence-based therapies such as 12-step facilitation, anger management, and brief interventions. They welcome adults, both male and female, including those managing co-occurring mental health and substance use conditions, to receive personalized care.
Pathways Counseling Center Inc, located in Ottawa, OH, delivers a wide range of rehabilitation services for adults and elderly clients. Their programs are specifically designed for treating substance use disorders, providing transitional housing, and addressing co-occurring mental health challenges alongside substance use. The center employs techniques like cognitive behavioral therapy and the 12-step method, offering both intensive outpatient and standard outpatient services, which include methadone or buprenorphine treatments. Pathways Counseling Center Inc prioritizes individualized support for adult men, women, and teenagers, ensuring that each person receives the care that best meets their needs. Their dedication to high-quality treatment makes them a reputable option for those in pursuit of effective addiction recovery solutions.
Pathways Inc, situated in Louisa, KY, provides an extensive selection of outpatient services tailored to address substance use issues and concurrent mental health conditions. The center emphasizes personalized treatment plans utilizing techniques like anger management, cognitive behavioral therapy, and short intervention strategies. It serves a wide array of individuals, including teenagers, individuals who have experienced intimate partner violence, and those dealing with trauma. With dedicated programs designed for adults and seniors of various gender identities, this facility is committed to delivering high-quality care and assistance for individuals on their journey to recovery from addiction and mental health difficulties.
Pathways Inc, situated in Grayson, KY, provides premier treatment for substance use and transitional housing solutions. This center focuses on addressing co-occurring substance use issues and significant mental health challenges in adults, as well as emotional problems in children. The offerings include 12-step facilitation and anger management strategies, delivering long-term residential support specifically aimed at adult women, pregnant or postpartum women, seniors, and young adults. Renowned for its exceptional care and tailored programs for women, Pathways Inc is recognized as a reliable source for extensive rehabilitation services.
Situated in Ashland, KY, Pathways Inc provides a wide array of services aimed at addressing addiction for both adults and young adults. This center focuses on delivering targeted care, including detox services, treatment for substance use disorders, and support for those facing both addiction and significant mental health challenges. With options for residential detox, round-the-clock residential care, and short-term residential programs, Pathways Inc customizes its treatment plans to fit the unique needs of each individual. The facility adopts methods such as 12-step support, anger management techniques, and short interventions to promote a well-rounded recovery experience. Additionally, specialized programs for active-duty military personnel, individuals with dual diagnoses, and their family members distinguish this center. Pathways Inc is dedicated to providing high-quality care for all clients, regardless of gender, in their journey to overcome addiction.
Situated in Grayson, KY, Pathways Inc delivers a wide range of treatment options for adults facing substance use issues alongside mental health conditions, as well as for children dealing with significant emotional challenges. Their outpatient services encompass intensive outpatient care and specific programs for methadone/buprenorphine or naltrexone treatments. The methodologies employed at the center incorporate 12-step facilitation, anger management strategies, and brief intervention principles. Pathways Inc also offers customized programs for adolescents, and for those who have confronted trauma, intimate partner violence, or domestic violence. Catering to adults and seniors across all genders, this facility emphasizes personalized care and tailored treatment plans aimed at fostering sustained recovery.
Situated in Ashland, KY, Pathways Inc stands out as a leading rehabilitation center focused on outpatient care for individuals facing substance use issues alongside mental health challenges, catering to both adults and children. This center offers targeted programs that address the complexities of co-occurring disorders, ensuring that each client receives personalized treatment. With methods such as 12-step programming, anger management strategies, and brief intervention sessions, Pathways Inc promotes a comprehensive and effective healing process. Accommodating adults and seniors of all genders, the center distinguishes itself with its outpatient options for methadone, buprenorphine, or naltrexone, all delivered within a nurturing and supportive setting.
Pathways Inc, located in Mount Sterling, KY, provides extensive addiction treatment and focused support for those facing combined mental health challenges. Their customized approaches feature intensive outpatient services, standard outpatient care, and medication-assisted therapy aimed at achieving lasting sobriety. Employing proven methods such as cognitive behavioral therapy and anger management techniques, this center fosters a nurturing setting for adults and older adults. Specializing in care for young people, individuals with dual diagnoses, and those involved in the justice system, Pathways Inc delivers individualized attention to all clients regardless of gender. Discover excellent treatment and impactful strategies at this premier recovery facility.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.